Clinical Trial Update: Perampanel Titration and Cognitive Effects [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating perampanel titration and cognitive effects in epilepsy. The study was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Fycompa (perampanel)

Snippet

Sponsor: Kimford Jay Meador | Conditions: Epilepsy | Phase 4 | Status: TERMINATED | Results posted: 2024-06-06